Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Finasteride reduces prostate size and PSA levels in young patients.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.